| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | pituitary gonadotropin complex | 6.58e-06 | 8 | 104 | 3 | GO:0061696 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 3.63e-04 | 6 | 104 | 2 | GO:0005587 | |
| GeneOntologyCellularComponent | synaptic cleft | 5.86e-04 | 33 | 104 | 3 | GO:0043083 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 6.73e-04 | 8 | 104 | 2 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 6.73e-04 | 8 | 104 | 2 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 6.73e-04 | 8 | 104 | 2 | GO:0098645 | |
| Domain | Glyco_hormone_CN | 1.01e-06 | 15 | 100 | 4 | IPR006208 | |
| Domain | Cys_knot | 1.01e-06 | 15 | 100 | 4 | PF00007 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 1.85e-06 | 69 | 100 | 6 | IPR020636 | |
| Domain | Gonadotropin_bsu_CS | 2.94e-06 | 6 | 100 | 3 | IPR018245 | |
| Domain | Gonadotropin_bsu | 5.13e-06 | 7 | 100 | 3 | IPR001545 | |
| Domain | GLYCO_HORMONE_BETA_2 | 5.13e-06 | 7 | 100 | 3 | PS00689 | |
| Domain | GHB | 5.13e-06 | 7 | 100 | 3 | SM00068 | |
| Domain | GLYCO_HORMONE_BETA_1 | 5.13e-06 | 7 | 100 | 3 | PS00261 | |
| Domain | Thioredoxin/glutathione_Rdtase | 8.48e-05 | 3 | 100 | 2 | IPR006338 | |
| Domain | CARBOXYPEPT_ZN_2 | 1.36e-04 | 19 | 100 | 3 | PS00133 | |
| Domain | CARBOXYPEPT_ZN_1 | 1.59e-04 | 20 | 100 | 3 | PS00132 | |
| Domain | Peptidase_M14 | 2.44e-04 | 23 | 100 | 3 | PF00246 | |
| Domain | Peptidase_M14 | 2.44e-04 | 23 | 100 | 3 | IPR000834 | |
| Domain | Pyr_OxRdtase_I_AS | 2.81e-04 | 5 | 100 | 2 | IPR012999 | |
| Domain | Pyr_redox_dim | 2.81e-04 | 5 | 100 | 2 | PF02852 | |
| Domain | DMAP_binding | 2.81e-04 | 5 | 100 | 2 | PF06464 | |
| Domain | PYRIDINE_REDOX_1 | 2.81e-04 | 5 | 100 | 2 | PS00076 | |
| Domain | C4 | 4.20e-04 | 6 | 100 | 2 | SM00111 | |
| Domain | - | 4.20e-04 | 6 | 100 | 2 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 4.20e-04 | 6 | 100 | 2 | IPR001442 | |
| Domain | DCX | 4.20e-04 | 6 | 100 | 2 | SM00537 | |
| Domain | C4 | 4.20e-04 | 6 | 100 | 2 | PF01413 | |
| Domain | DMAP1-bd | 4.20e-04 | 6 | 100 | 2 | IPR010506 | |
| Domain | DMAP_binding | 4.20e-04 | 6 | 100 | 2 | SM01137 | |
| Domain | NC1_IV | 4.20e-04 | 6 | 100 | 2 | PS51403 | |
| Domain | AMP-binding | 5.44e-04 | 30 | 100 | 3 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 5.44e-04 | 30 | 100 | 3 | IPR000873 | |
| Domain | - | 5.86e-04 | 7 | 100 | 2 | 3.30.390.30 | |
| Domain | - | 5.86e-04 | 7 | 100 | 2 | 3.10.20.230 | |
| Domain | DCX | 5.86e-04 | 7 | 100 | 2 | PF03607 | |
| Domain | Hirudin/antistatin | 5.86e-04 | 7 | 100 | 2 | IPR011061 | |
| Domain | - | 7.78e-04 | 8 | 100 | 2 | 3.30.70.340 | |
| Domain | Pyr_nucl-diS_OxRdtase_dimer | 7.78e-04 | 8 | 100 | 2 | IPR004099 | |
| Domain | FAD/NAD-linked_Rdtase_dimer | 7.78e-04 | 8 | 100 | 2 | IPR016156 | |
| Domain | Propep_M14 | 7.78e-04 | 8 | 100 | 2 | PF02244 | |
| Domain | M14A_act_pep | 7.78e-04 | 8 | 100 | 2 | IPR003146 | |
| Domain | DC | 7.78e-04 | 8 | 100 | 2 | PS50309 | |
| Domain | Doublecortin_dom | 7.78e-04 | 8 | 100 | 2 | IPR003533 | |
| Domain | SEA | 2.48e-03 | 14 | 100 | 2 | SM00200 | |
| Domain | - | 2.85e-03 | 15 | 100 | 2 | 3.30.70.960 | |
| Domain | Propept_inh | 3.66e-03 | 17 | 100 | 2 | IPR009020 | |
| Domain | Zn_pept | 4.11e-03 | 18 | 100 | 2 | SM00631 | |
| Domain | EGF_CA | 4.19e-03 | 122 | 100 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 4.44e-03 | 124 | 100 | 4 | IPR001881 | |
| Domain | Pyr_redox_2 | 4.57e-03 | 19 | 100 | 2 | PF07992 | |
| Domain | - | 5.57e-03 | 67 | 100 | 3 | 2.10.90.10 | |
| Domain | Cystine-knot_cytokine | 5.57e-03 | 67 | 100 | 3 | IPR029034 | |
| Domain | SRCR | 5.58e-03 | 21 | 100 | 2 | PF00530 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 9.46e-05 | 18 | 71 | 3 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 9.46e-05 | 18 | 71 | 3 | MM14882 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.18e-04 | 59 | 71 | 4 | M27218 | |
| Pathway | BIOCARTA_NOTCH_PATHWAY | 3.70e-04 | 6 | 71 | 2 | MM1584 | |
| Pathway | BIOCARTA_NOTCH_PATHWAY | 3.70e-04 | 6 | 71 | 2 | M22074 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 4.51e-04 | 30 | 71 | 3 | M27216 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 4.69e-04 | 72 | 71 | 4 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 4.95e-04 | 73 | 71 | 4 | MM15906 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 5.17e-04 | 7 | 71 | 2 | M27199 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 5.77e-04 | 76 | 71 | 4 | M27219 | |
| Pathway | WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS | 8.80e-04 | 9 | 71 | 2 | M39869 | |
| Pathway | WP_CANCER_PATHWAYS | 9.61e-04 | 507 | 71 | 9 | M48302 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.10e-03 | 10 | 71 | 2 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.10e-03 | 10 | 71 | 2 | MM1560 | |
| Pathway | WP_GENE_REGULATORY_NETWORK_MODELLING_SOMITOGENESIS | 1.10e-03 | 10 | 71 | 2 | MM15839 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.22e-03 | 42 | 71 | 3 | M7169 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.31e-03 | 43 | 71 | 3 | M53 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.34e-03 | 11 | 71 | 2 | M15422 | |
| Pathway | WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS | 1.34e-03 | 11 | 71 | 2 | M39647 | |
| Pathway | BIOCARTA_HES_PATHWAY | 1.60e-03 | 12 | 71 | 2 | MM1562 | |
| Pathway | BIOCARTA_HES_PATHWAY | 1.60e-03 | 12 | 71 | 2 | M22042 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 1.60e-03 | 12 | 71 | 2 | MM1526 | |
| Pathway | REACTOME_MINERALOCORTICOID_BIOSYNTHESIS | 1.60e-03 | 12 | 71 | 2 | MM14749 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.88e-03 | 13 | 71 | 2 | MM1347 | |
| Pathway | REACTOME_GLYCOPROTEIN_HORMONES | 1.88e-03 | 13 | 71 | 2 | MM14830 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 1.88e-03 | 13 | 71 | 2 | M47423 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 1.88e-03 | 13 | 71 | 2 | M12950 | |
| Pathway | REACTOME_REACTIONS_SPECIFIC_TO_THE_COMPLEX_N_GLYCAN_SYNTHESIS_PATHWAY | 1.88e-03 | 13 | 71 | 2 | MM15701 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.03e-03 | 50 | 71 | 3 | MM14796 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 2.19e-03 | 14 | 71 | 2 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 2.19e-03 | 14 | 71 | 2 | M47388 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.19e-03 | 14 | 71 | 2 | MM1458 | |
| Pathway | BIOCARTA_PS1_PATHWAY | 2.19e-03 | 14 | 71 | 2 | MM1459 | |
| Pathway | BIOCARTA_PS1_PATHWAY | 2.19e-03 | 14 | 71 | 2 | M16173 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 2.19e-03 | 14 | 71 | 2 | M6487 | |
| Pathway | REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS | 2.52e-03 | 15 | 71 | 2 | MM14832 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 2.52e-03 | 15 | 71 | 2 | M47385 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 2.52e-03 | 15 | 71 | 2 | M27161 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.52e-03 | 15 | 71 | 2 | MM14922 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 2.52e-03 | 15 | 71 | 2 | M27202 | |
| Pathway | REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS | 2.52e-03 | 15 | 71 | 2 | MM14972 | |
| Pathway | REACTOME_ANDROGEN_BIOSYNTHESIS | 2.52e-03 | 15 | 71 | 2 | MM14739 | |
| Pubmed | 1.17e-09 | 6 | 105 | 4 | 16684769 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FLNA EPPK1 INPP5E HECTD4 TXNRD2 PTCH1 DLL1 BIRC6 KIFC2 KCNH3 DIP2A ADAMTS7 NAPRT PI4KA DIP2C AGRN NOTCH1 | 3.58e-08 | 1105 | 105 | 17 | 35748872 |
| Pubmed | 5.49e-08 | 13 | 105 | 4 | 12682087 | ||
| Pubmed | 9.20e-08 | 37 | 105 | 5 | 24673559 | ||
| Pubmed | 1.07e-07 | 4 | 105 | 3 | 17056143 | ||
| Pubmed | 2.66e-07 | 5 | 105 | 3 | 2468994 | ||
| Pubmed | The beta chorionic gonadotropin-beta luteinizing gene cluster maps to human chromosome 19. | 5.31e-07 | 6 | 105 | 3 | 6204923 | |
| Pubmed | 5.31e-07 | 6 | 105 | 3 | 2422163 | ||
| Pubmed | The beta subunit of human chorionic gonadotropin is encoded by multiple genes. | 5.31e-07 | 6 | 105 | 3 | 6194155 | |
| Pubmed | 5.31e-07 | 6 | 105 | 3 | 1371113 | ||
| Pubmed | 5.31e-07 | 6 | 105 | 3 | 6319099 | ||
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 6690982 | ||
| Pubmed | 1.48e-06 | 8 | 105 | 3 | 16141228 | ||
| Pubmed | 1.48e-06 | 8 | 105 | 3 | 11264466 | ||
| Pubmed | 1.48e-06 | 8 | 105 | 3 | 11683410 | ||
| Pubmed | 2.22e-06 | 9 | 105 | 3 | 8562707 | ||
| Pubmed | PAR3 restricts the expansion of neural precursor cells by regulating hedgehog signaling. | 3.00e-06 | 33 | 105 | 4 | 36218069 | |
| Pubmed | The doublecortin gene family and disorders of neuronal structure. | 3.16e-06 | 10 | 105 | 3 | 20236041 | |
| Pubmed | 3.16e-06 | 10 | 105 | 3 | 16869982 | ||
| Pubmed | 3.39e-06 | 34 | 105 | 4 | 17015435 | ||
| Pubmed | 4.33e-06 | 11 | 105 | 3 | 14998921 | ||
| Pubmed | 5.77e-06 | 12 | 105 | 3 | 16024816 | ||
| Pubmed | Jagged1 is Essential for Radial Glial Maintenance in the Cortical Proliferative Zone. | 7.48e-06 | 13 | 105 | 3 | 31202705 | |
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 7.48e-06 | 13 | 105 | 3 | 9833687 | |
| Pubmed | Effect of selenium on thioredoxin reductase activity in Txnrd1 or Txnrd2 hemizygous mice. | 9.03e-06 | 2 | 105 | 2 | 17937623 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 12137943 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 9537506 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 7987396 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 29742505 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 38214412 | ||
| Pubmed | Cis-interactions between Notch and Delta generate mutually exclusive signalling states. | 9.03e-06 | 2 | 105 | 2 | 20418862 | |
| Pubmed | COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome. | 9.03e-06 | 2 | 105 | 2 | 24052634 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 19357112 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 25229338 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 26014475 | ||
| Pubmed | Persistent familial hematuria in children and the locus for thin basement membrane nephropathy. | 9.03e-06 | 2 | 105 | 2 | 16235097 | |
| Pubmed | Notch1 endocytosis is induced by ligand and is required for signal transduction. | 9.03e-06 | 2 | 105 | 2 | 26522918 | |
| Pubmed | Resolution of oxidative stress by thioredoxin reductase: Cysteine versus selenocysteine. | 9.03e-06 | 2 | 105 | 2 | 24624337 | |
| Pubmed | Presumed COL4A3/COL4A4 Missense/Synonymous Variants Induce Aberrant Splicing. | 9.03e-06 | 2 | 105 | 2 | 35386907 | |
| Pubmed | COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome. | 9.03e-06 | 2 | 105 | 2 | 12028435 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 18661361 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 37321467 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 18350150 | ||
| Pubmed | Notch1 induces enhanced expression of Delta-like-1 in the U251MG glioma cell line. | 9.03e-06 | 2 | 105 | 2 | 19724883 | |
| Pubmed | Doublecortin-like kinase enhances dendritic remodelling and negatively regulates synapse maturation. | 9.03e-06 | 2 | 105 | 2 | 23385585 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 23732520 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 1820200 | ||
| Pubmed | Mutation analysis of COL4A3 and COL4A4 genes in a Chinese autosomal-dominant Alport syndrome family. | 9.03e-06 | 2 | 105 | 2 | 28674241 | |
| Pubmed | Epigenetic regulation of Delta-Like1 controls Notch1 activation in gastric cancer. | 9.03e-06 | 2 | 105 | 2 | 22249198 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 21172426 | ||
| Pubmed | NOTCH, a new signaling pathway implicated in holoprosencephaly. | 9.03e-06 | 2 | 105 | 2 | 21196490 | |
| Pubmed | Heterozygous COL4A3/COL4A4 mutations: the hidden part of the iceberg? | 9.03e-06 | 2 | 105 | 2 | 35090027 | |
| Pubmed | Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases. | 9.03e-06 | 2 | 105 | 2 | 17216251 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 35369551 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 6774259 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 25307543 | ||
| Pubmed | Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome. | 9.03e-06 | 2 | 105 | 2 | 27281700 | |
| Pubmed | [From Alport syndrome to benign familial hematuria: clinical and genetic aspect]. | 9.03e-06 | 2 | 105 | 2 | 16895672 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 19595745 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 12768082 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 17942953 | ||
| Pubmed | Polymorphisms in COL4A3 and COL4A4 genes associated with keratoconus. | 9.03e-06 | 2 | 105 | 2 | 20029656 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 10721726 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 25381091 | ||
| Pubmed | Heterogeneity within animal thioredoxin reductases. Evidence for alternative first exon splicing. | 9.03e-06 | 2 | 105 | 2 | 11060283 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 12121668 | ||
| Pubmed | Collagen type IV (alpha3-alpha4) nephropathy: from isolated haematuria to renal failure. | 9.03e-06 | 2 | 105 | 2 | 15280517 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 15880327 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 7723844 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 17878313 | ||
| Pubmed | Spatiotemporal oscillations of Notch1, Dll1 and NICD are coordinated across the mouse PSM. | 9.03e-06 | 2 | 105 | 2 | 25468943 | |
| Pubmed | Polymorphism analysis of COL4A3 and COL4A4 genes in Greek patients with keratoconus. | 9.03e-06 | 2 | 105 | 2 | 25083577 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 20847057 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 21643850 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 32232700 | ||
| Pubmed | Identification of a novel progenitor cell marker, grainyhead-like 2 in the developing pituitary. | 9.50e-06 | 14 | 105 | 3 | 27564454 | |
| Pubmed | Defective Nodal and Cerl2 expression in the Arl13b(hnn) mutant node underlie its heterotaxia. | 9.50e-06 | 14 | 105 | 3 | 22554696 | |
| Pubmed | Tbx1 regulates population, proliferation and cell fate determination of otic epithelial cells. | 1.18e-05 | 15 | 105 | 3 | 17074316 | |
| Pubmed | 1.18e-05 | 15 | 105 | 3 | 10625553 | ||
| Pubmed | 1.18e-05 | 15 | 105 | 3 | 9264260 | ||
| Pubmed | Erk and MAPK signaling is essential for intestinal development through Wnt pathway modulation. | 1.27e-05 | 47 | 105 | 4 | 32747435 | |
| Pubmed | 1.46e-05 | 16 | 105 | 3 | 15878328 | ||
| Pubmed | 1.46e-05 | 16 | 105 | 3 | 29352015 | ||
| Pubmed | 1.46e-05 | 16 | 105 | 3 | 32161758 | ||
| Pubmed | FGFR1 is required for the development of the auditory sensory epithelium. | 1.76e-05 | 17 | 105 | 3 | 12194867 | |
| Pubmed | 2.50e-05 | 19 | 105 | 3 | 20335360 | ||
| Pubmed | 2.50e-05 | 19 | 105 | 3 | 27234308 | ||
| Pubmed | Primary cilia maintain corneal epithelial homeostasis by regulation of the Notch signaling pathway. | 2.50e-05 | 19 | 105 | 3 | 27122169 | |
| Pubmed | 2.50e-05 | 19 | 105 | 3 | 15689378 | ||
| Pubmed | Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome. | 2.70e-05 | 3 | 105 | 2 | 27576055 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 18320325 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 19523396 | ||
| Pubmed | A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen α3α4α5(IV) trimers. | 2.70e-05 | 3 | 105 | 2 | 24522496 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 7962065 | ||
| Pubmed | Activation of Notch signal pathway is associated with a poorer prognosis in acute myeloid leukemia. | 2.70e-05 | 3 | 105 | 2 | 20812035 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 28704582 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 21985982 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 12050162 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 21622856 | ||
| Pubmed | Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGS. | 2.70e-05 | 3 | 105 | 2 | 30647093 | |
| Interaction | HTR3E interactions | 6.72e-06 | 8 | 101 | 3 | int:HTR3E | |
| Interaction | TREML2 interactions | 8.16e-06 | 26 | 101 | 4 | int:TREML2 | |
| Cytoband | 8q24.3 | 1.37e-04 | 113 | 105 | 4 | 8q24.3 | |
| GeneFamily | Doublecortin superfamily | 5.73e-06 | 10 | 67 | 3 | 1369 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.66e-06 | 182 | 105 | 6 | 52eac2f892ea7f26731e0b21c578fd2665a1657a | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.44e-06 | 187 | 105 | 6 | b8f88599e22b9b345c7ec3bbecd87a8b2a033f9f | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.96e-06 | 190 | 105 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 6.14e-06 | 191 | 105 | 6 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.33e-06 | 197 | 105 | 6 | 236a40eb6c08e1d179cf0fb5450b032975c5f6b6 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-KRT5-/KRT17+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 7.77e-06 | 199 | 105 | 6 | 3b1f56c8b40bb36922a31d2d440a8c468a8aa3f1 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.84e-05 | 150 | 105 | 5 | 4bdcdce40f54580c7a4e1416b468e657ba8874fc | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.06e-05 | 81 | 105 | 4 | 8cb94dda18010b3b05e5ab72235850483013c03a | |
| ToppCell | facs-Trachea-18m-Epithelial-glandular_epithelial-lung_secretory_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.36e-05 | 164 | 105 | 5 | cdb8cd2d6b369189ea77e4946738e2816d502e03 | |
| ToppCell | facs-Trachea-18m-Epithelial-glandular_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.36e-05 | 164 | 105 | 5 | 5dbfcdd450f652b16d97da53b528d4584b0eabcf | |
| ToppCell | facs-Trachea-18m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.36e-05 | 164 | 105 | 5 | f1423f4434af4af9c60c8a5b0b0abec4a7df9401 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 4.88e-05 | 168 | 105 | 5 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.77e-05 | 174 | 105 | 5 | 46bd0ef7d0541386de7a901d85d53d0176dc92bf | |
| ToppCell | AT1-AT2_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 5.93e-05 | 175 | 105 | 5 | 9a95ab5c361ebaa8747983c5a0d69025682a19ad | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.93e-05 | 175 | 105 | 5 | 711ace94fa9a763c6ae48171a690953f25deebe4 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 175 | 105 | 5 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_T-T_NK-NK_T_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.09e-05 | 176 | 105 | 5 | f0c01fc4f9c17c4d724642d9931731eef2b10258 | |
| ToppCell | Healthy_Control-Lymphoid-NK-NK|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 6.43e-05 | 178 | 105 | 5 | 71e99f143009b2d29cb47b96393b58b514c8cfc6 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-05 | 178 | 105 | 5 | 09a215a0d6e98e4bb920cabda12af08ff4de3c98 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.43e-05 | 178 | 105 | 5 | a3af5d9c55858e36be0498081029ecb0acaeb3d3 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.43e-05 | 178 | 105 | 5 | b3b88989bd602cfb55bb5c47731deb99288a8952 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK-T_NK-ILC_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.60e-05 | 179 | 105 | 5 | d18a520568cf4b031972d3dd7d4d4bd073ac1fea | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 6.60e-05 | 179 | 105 | 5 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_NK-T_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.77e-05 | 180 | 105 | 5 | 0a98d21fec67a890e75ebf0e2d23adddd77da214 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-ILC_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.77e-05 | 180 | 105 | 5 | 27672ac6a02172a31851f18decb9acffa8f5a703 | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 6.77e-05 | 180 | 105 | 5 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.77e-05 | 180 | 105 | 5 | 1c8398342d3fa4d5ca9a8a63626cc497c5291446 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.77e-05 | 180 | 105 | 5 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.77e-05 | 180 | 105 | 5 | ddbab26b05f057bd78b78773381cd447bd2e2726 | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-Cd3e_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.14e-05 | 182 | 105 | 5 | da3e9093cba791c7c282eb044656046252a32789 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.32e-05 | 183 | 105 | 5 | 263937906ddabc798bbe60f0da28ba859a5c72e2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.51e-05 | 184 | 105 | 5 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | wk_08-11-Epithelial-PNS-PCP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.51e-05 | 184 | 105 | 5 | eac2a9089913f33a961ba11519b53645790f2056 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.89e-05 | 96 | 105 | 4 | 7e02df1f28fea1d962f9b1d3835212765a6642cc | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.91e-05 | 186 | 105 | 5 | 1e3ab663e4756975db6d802b2c6c054a94a79393 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 8.11e-05 | 187 | 105 | 5 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_memory-B_memory-0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.32e-05 | 188 | 105 | 5 | 229108e7e3db49e1cfd747d69e338394139d95b3 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-05 | 189 | 105 | 5 | bba28f57a0708515fdd5acd9592dbbe4a4f57116 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-05 | 189 | 105 | 5 | cf293b23a4c0e8a0c9f09115b1d53d9b11de72e2 | |
| ToppCell | facs-BAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-05 | 189 | 105 | 5 | 87323e86a5b5d159920a07e6bd7ef5e3438cd085 | |
| ToppCell | COVID-19_Severe-Lymphoid_B-B_memory|COVID-19_Severe / Disease group, lineage and cell class | 8.74e-05 | 190 | 105 | 5 | b6510c419a15ed049c0a0a6a6697b643668741c3 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.96e-05 | 191 | 105 | 5 | b7d17d3ba488378b30f3732f8109f4a7c1673e61 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 8.96e-05 | 191 | 105 | 5 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.18e-05 | 192 | 105 | 5 | 55f95454399fd533df75db06584eaa48d6ee3830 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 9.18e-05 | 192 | 105 | 5 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_memory|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.18e-05 | 192 | 105 | 5 | 72f936f03bb9b58c1ccaaf8270c07f5bbf2ac355 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_memory-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.18e-05 | 192 | 105 | 5 | dac61f0b374f6f9476eedce97f341f26c1bc037c | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_memory|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.18e-05 | 192 | 105 | 5 | 149ea3f0181f194ccf141583b08af033ef9fc7c1 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-mucus_secreting_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-05 | 193 | 105 | 5 | 3038ed3e53d3367136fac5c9773cd5b7414f49d3 | |
| ToppCell | facs-Trachea-3m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.41e-05 | 193 | 105 | 5 | c5925b3b5d19098e3987789d68a493d7fd548ac9 | |
| ToppCell | facs-Trachea-3m-Epithelial-glandular_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.41e-05 | 193 | 105 | 5 | 6905de261d90dfe3dd2c2cf5b2e26afb2bcc3d5b | |
| ToppCell | facs-Trachea-3m-Epithelial-glandular_epithelial-lung_secretory_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.41e-05 | 193 | 105 | 5 | f73630725f093c646bdaf178c39505c04a16e2c6 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 9.64e-05 | 194 | 105 | 5 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Cytotoxic_CD8+_T|metastatic_Lymph_Node / Location, Cell class and cell subclass | 9.64e-05 | 194 | 105 | 5 | 73c057b623829de793616d9d373a0018071d51d8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.64e-05 | 194 | 105 | 5 | a7731378f44ca1a229311686caf5740c742d21ba | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.87e-05 | 195 | 105 | 5 | 717e6a66bad50e711442d71360b540789646b334 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 9.87e-05 | 195 | 105 | 5 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_II_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.87e-05 | 195 | 105 | 5 | 0e3aac1b1a1fd483f5fb9a394eb90c0e1ce63542 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.87e-05 | 195 | 105 | 5 | 10774b5ce17d4edd23dbf4709b11cc87cc2b87be | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-04 | 196 | 105 | 5 | 40e6900a0d56088a40d37ec312f53207ea952602 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-04 | 196 | 105 | 5 | 9a420a4eb46cb554bec641726fea5398ff60f630 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 196 | 105 | 5 | f068ce40bf35021baf1468ae9ce30a92162eb14d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-04 | 196 | 105 | 5 | 7acd782a587b7d331517f60daa8b5c2177bedfc7 | |
| ToppCell | Epithelial-Epithelial-A_(AT1)|Epithelial / shred on cell class and cell subclass (v4) | 1.01e-04 | 196 | 105 | 5 | 41b21a18125cc95bc8adde3369e4abd029cf137d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-04 | 196 | 105 | 5 | cb5860f580b477bfa52b22cdc21b808e1371e6e0 | |
| ToppCell | severe_COVID-19-B_memory|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.01e-04 | 196 | 105 | 5 | c6e00cb59a88b9903cca233cefe05f80c5ea4153 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-04 | 196 | 105 | 5 | 0b247cf981981ae61aca5de82ef687e8d783c9ef | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.01e-04 | 196 | 105 | 5 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.04e-04 | 197 | 105 | 5 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.04e-04 | 197 | 105 | 5 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | Control-B_memory-3|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.04e-04 | 197 | 105 | 5 | b86385c6c1d52ef4e3d855004d77afab61556978 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-04 | 197 | 105 | 5 | 12370ee857fddf1cf26196b23c21b68dcea48eb3 | |
| ToppCell | severe_COVID-19-B_intermediate|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.04e-04 | 197 | 105 | 5 | 3ba64850b344cb24a4d20d64392a0b2752950d40 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-04 | 197 | 105 | 5 | af819b0561c8db582c5b466d804153d69d3297e0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.04e-04 | 197 | 105 | 5 | 983502a99e6d59bb36225b0246a9990604de1a01 | |
| ToppCell | mild-Plasmablast|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.04e-04 | 197 | 105 | 5 | 21085d5e27b5a23a241a933058bb89f8a1fcf198 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 197 | 105 | 5 | 5fbbc570a4e77c703f569a4f85ce2d8af67d6297 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.04e-04 | 197 | 105 | 5 | 965d5a3f8c9b12cb8a8d3429702ae29ebd8c6122 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial-Astroglia|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.04e-04 | 197 | 105 | 5 | 3f088eb29197bc575400d6dafd8083e69e4a149f | |
| ToppCell | NS-critical-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.04e-04 | 197 | 105 | 5 | a72047b7428c0d4aaf016c1ac23dc30919260fd8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 197 | 105 | 5 | 7b12f9d4ad1e84df58e86591a491c84d4f36eac5 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.04e-04 | 197 | 105 | 5 | d4dfb3b561d0783cdbee4e8d27009ad81df695cb | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-04 | 198 | 105 | 5 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 198 | 105 | 5 | 97ae237f955fd5fbd01d06aafe89ef9e6f777a9a | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.09e-04 | 199 | 105 | 5 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-04 | 199 | 105 | 5 | a1635a52318be0423f8e4fc03d971c28cd22b57e | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B-B_memory|COVID-19_Severe / Disease, condition lineage and cell class | 1.09e-04 | 199 | 105 | 5 | 24c05faa825c9d55279956469862440f9914a280 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-04 | 199 | 105 | 5 | 8f2fff877ca53226f1f5be02c234b911dd29fb20 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Transitional_AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.11e-04 | 200 | 105 | 5 | 1ba6327851aa61e9a1f1fe1671bc27929d93ac74 | |
| ToppCell | Biopsy_IPF-Epithelial-KRT5-/KRT17+|Biopsy_IPF / Sample group, Lineage and Cell type | 1.11e-04 | 200 | 105 | 5 | 2fc7a3b3aea711ad3d96fd9513f4b40533056d86 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.11e-04 | 200 | 105 | 5 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | Control-B_memory-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.12e-04 | 124 | 105 | 4 | 3e987915026f503e8d072a837b6e7a34252e5c63 | |
| ToppCell | LPS_only-Endothelial-Epi-like|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.25e-04 | 126 | 105 | 4 | 4c598f7bae09aca7a4ecce63dfd6890b26468c73 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-04 | 126 | 105 | 4 | 4eeea015efe17e0aae5bd76b71fa70b5149dfada | |
| ToppCell | LPS_only-Endothelial-Epi-like-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.25e-04 | 126 | 105 | 4 | e065304f480a5e38532b66508b0ee87cc48bba9b | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-2|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.32e-04 | 127 | 105 | 4 | 018ffd9ff1913787cb0086a8581b399a121eaba1 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Biphasic-3|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 2.32e-04 | 127 | 105 | 4 | df2854bcb2708ddc13b3ca48c03887380e827790 | |
| Disease | dyslexia (implicated_via_orthology) | 1.03e-05 | 2 | 95 | 2 | DOID:4428 (implicated_via_orthology) | |
| Disease | benign familial hematuria (is_implicated_in) | 1.03e-05 | 2 | 95 | 2 | DOID:0111365 (is_implicated_in) | |
| Disease | Alport syndrome, recessive type | 1.03e-05 | 2 | 95 | 2 | C2931254 | |
| Disease | Alport syndrome, dominant type | 1.03e-05 | 2 | 95 | 2 | C2931253 | |
| Disease | ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE | 1.03e-05 | 2 | 95 | 2 | C4746745 | |
| Disease | autosomal recessive Alport syndrome (is_implicated_in) | 1.03e-05 | 2 | 95 | 2 | DOID:0110033 (is_implicated_in) | |
| Disease | Thin basement membrane disease | 1.03e-05 | 2 | 95 | 2 | C0403440 | |
| Disease | Benign familial hematuria | 1.03e-05 | 2 | 95 | 2 | cv:C0241908 | |
| Disease | carboxypeptidase A4 measurement | 1.03e-05 | 2 | 95 | 2 | EFO_0801452 | |
| Disease | Morphological abnormality of the central nervous system | 1.03e-05 | 2 | 95 | 2 | C4021765 | |
| Disease | autosomal recessive Alport syndrome (implicated_via_orthology) | 3.07e-05 | 3 | 95 | 2 | DOID:0110033 (implicated_via_orthology) | |
| Disease | Alport syndrome | 3.07e-05 | 3 | 95 | 2 | cv:C1567741 | |
| Disease | Collagen IV-related nephropathies | 3.07e-05 | 3 | 95 | 2 | cv:CN076135 | |
| Disease | Hematuria, Benign Familial | 6.13e-05 | 4 | 95 | 2 | C0241908 | |
| Disease | Alport Syndrome | 6.13e-05 | 4 | 95 | 2 | C1567741 | |
| Disease | Alport Syndrome, X-Linked | 1.02e-04 | 5 | 95 | 2 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 1.02e-04 | 5 | 95 | 2 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 1.02e-04 | 5 | 95 | 2 | C1567744 | |
| Disease | hypertensive nephropathy | 1.53e-04 | 6 | 95 | 2 | C0848548 | |
| Disease | Scoliosis, unspecified | 2.84e-04 | 8 | 95 | 2 | C0036439 | |
| Disease | myopathy (implicated_via_orthology) | 5.03e-04 | 48 | 95 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | collagen disease (implicated_via_orthology) | 6.63e-04 | 12 | 95 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | respiratory quotient | 9.10e-04 | 14 | 95 | 2 | EFO_0005189 | |
| Disease | chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology) | 9.10e-04 | 14 | 95 | 2 | DOID:0060413 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of skin | 9.22e-04 | 59 | 95 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 9.22e-04 | 59 | 95 | 3 | C0037286 | |
| Disease | Alobar Holoprosencephaly | 1.05e-03 | 15 | 95 | 2 | C0431363 | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.17e-03 | 64 | 95 | 3 | DOID:4947 (is_marker_for) | |
| Disease | Lobar Holoprosencephaly | 1.20e-03 | 16 | 95 | 2 | C0431362 | |
| Disease | Semilobar Holoprosencephaly | 1.20e-03 | 16 | 95 | 2 | C0751617 | |
| Disease | response to cyclophosphamide | 1.35e-03 | 17 | 95 | 2 | GO_1902518 | |
| Disease | psychotic symptoms | 1.78e-03 | 74 | 95 | 3 | EFO_0005940 | |
| Disease | Epilepsy, Cryptogenic | 2.38e-03 | 82 | 95 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 2.38e-03 | 82 | 95 | 3 | C0751111 | |
| Disease | Aura | 2.38e-03 | 82 | 95 | 3 | C0236018 | |
| Disease | Renal glomerular disease | 2.48e-03 | 23 | 95 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 2.48e-03 | 23 | 95 | 2 | C4521256 | |
| Disease | HDL cholesterol change measurement | 2.70e-03 | 24 | 95 | 2 | EFO_0007805 | |
| Disease | Sjogren's syndrome (is_marker_for) | 2.70e-03 | 24 | 95 | 2 | DOID:12894 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VFQPPASGGCYVTSL | 476 | P54793 | |
| VLITGPADTPYANGC | 4611 | Q9NR09 | |
| PGYELSFPAVLTCVG | 3261 | Q7Z407 | |
| AIPSCPEGTVPLYSG | 1456 | Q01955 | |
| PTSGTPLIGVYFALC | 301 | A5X5Y0 | |
| PPEGRTGVTQIGYCV | 696 | Q58F21 | |
| RYPANSIVVVGGCPV | 66 | O95415 | |
| VCDPYGGTKAPSTAA | 31 | Q5VWW1 | |
| YDPTTGKFTCSIPGI | 156 | Q5VWW1 | |
| CVCSPGYEPVSGAKT | 91 | P48960 | |
| SVPGSPVCGSDGVTY | 711 | O00468 | |
| SLSPTGVSRVCLYPG | 81 | Q96Q83 | |
| CGVPLSLGPFLVTYT | 86 | P06127 | |
| GCPRGVNPVVSYAVA | 121 | A6NKQ9 | |
| GLPGSSVIYCSVGNP | 451 | P53420 | |
| GPICSVIYQASGGSI | 351 | P48052 | |
| VSTPIGGLSYVQGCT | 51 | Q96CM8 | |
| VFSLLTGYCEPPTGV | 211 | P08574 | |
| PTVNFLATVTVPGYC | 2496 | Q96M86 | |
| LATYPGIIVSNICPG | 221 | Q9Y394 | |
| VRAPGVYVGTAPSGC | 51 | Q13515 | |
| APLPLGACGAYTTAI | 236 | Q96J87 | |
| GDSSAPSTCGVQVYP | 196 | Q9UKP4 | |
| VTASSAYAFPVPGCI | 276 | Q96MI9 | |
| SYCLQPPAGSVLSGT | 946 | Q9ULD8 | |
| VTPRFLCTGGVSPYA | 676 | P00751 | |
| VVPCLSSVVAGYGSP | 376 | Q14728 | |
| PAVVSCVPGPVYAAS | 276 | P58215 | |
| YTGATCEVVLAPCAP | 821 | P46531 | |
| GDICPVSYSSCPGIK | 566 | Q9NRR6 | |
| IYLPALGPDSCSVGI | 536 | O60291 | |
| SGTVGVPVSYTDCAP | 656 | Q4FZB7 | |
| DGPLYTVCGTPTYVA | 541 | O15075 | |
| TVCGTPTYVAPEIIA | 546 | O15075 | |
| ATVVEGPLYTVCGTP | 541 | Q8N568 | |
| FTVCGTPTYVAPEIL | 511 | Q9C098 | |
| GCPRGVNPVVSYAVA | 91 | P0DN87 | |
| ASVPCGLSVPCSGTY | 386 | P55316 | |
| VAGVECSPLVDGYIP | 896 | Q9HCM2 | |
| VFPYRVVATAPGCGV | 1881 | P42356 | |
| KGAFLYEPCGVSTPV | 446 | Q9NSB4 | |
| YEPCGVSTPVLSTGV | 451 | Q9NSB4 | |
| ETPRGCPVTSVTPYG | 4726 | P98088 | |
| GSPYVNGSLGEVTPC | 616 | Q76FK4 | |
| IVAYSITCPIIAPFG | 621 | O94886 | |
| ADYVVPGCQTVLSPT | 1481 | Q9Y4D8 | |
| VSATSSIAVYPCPGQ | 71 | Q5T319 | |
| ASKAIGSPGPDCVYV | 611 | Q9ULD6 | |
| TACGTPGYVAPELLE | 171 | Q6P2M8 | |
| PGSVLSTACGTPGYV | 171 | Q14012 | |
| STACGTPGYVAPEVL | 176 | Q14012 | |
| PVCPSYTVVGPSSVL | 126 | Q16633 | |
| ATAVSPGSCVPSLYV | 706 | O95996 | |
| ICPSIPGYGFSEASS | 181 | P07099 | |
| GCPRGVNPVVSYAVA | 91 | P0DN86 | |
| PCTYGSAVTPVLGVD | 76 | O00548 | |
| QDGTCSVSYLPVLPG | 1916 | P21333 | |
| PLVDGGSPISCYSVE | 686 | Q9Y2H6 | |
| CIPASSSFVYGAVPI | 511 | Q9H2C0 | |
| QVGPTCTTVYPASGS | 351 | Q9UI42 | |
| VAGYTIPPGHQVCVS | 396 | Q16850 | |
| CLQGTSGPDPTTVYV | 1306 | Q9Y2E4 | |
| SGTTVILTCPQYPGS | 41 | P07766 | |
| PVLSPESGIGSSYQC | 236 | O43638 | |
| SCENPRGPYVLVTGA | 96 | Q5VTJ3 | |
| TPPEEYCVQTGVTGV | 71 | P11047 | |
| VPCIASGVLVSYPSV | 291 | A6NN90 | |
| CLQGTAGPDPTTVYV | 1321 | Q14689 | |
| TLCVAGVLTIDPPYG | 126 | Q8WXD5 | |
| CVGPGATQLYVPTDA | 151 | Q3B7T3 | |
| YCISPKQVVVPAGGS | 1386 | Q9Y238 | |
| SVGPIDYVLPSCGII | 881 | Q9Y2H2 | |
| EGIPTGEPVCVYTAE | 451 | P22223 | |
| SVEPGPGGTVTTCYR | 426 | Q96AC6 | |
| ACSGLPPGKEVYAVV | 856 | Q96JN8 | |
| GTPYKVSCSPTSGAV | 56 | A1KXE4 | |
| GTGQALGLPPTTCVY | 6 | Q15077 | |
| AYLAVRSTPGVPCTV | 261 | Q15077 | |
| IGAPSSVNPGYCVSL | 126 | P05451 | |
| PLGLATLGATVCYPV | 141 | Q6UXV4 | |
| TILQATCPYSPAGGI | 216 | Q6NXP6 | |
| EKVTGPTATVYGCGT | 221 | Q9BW92 | |
| AVALGPAASYVCTPE | 786 | P84550 | |
| RSYGLSVVPEPAGCT | 316 | Q9NRR4 | |
| LGCDTGPVAGVTVPY | 441 | Q9UIG8 | |
| CTQVKGPEAGYVATP | 361 | Q8NBX0 | |
| VAVYCGSIPRTSAGP | 16 | Q6ZUX3 | |
| PYLEGSGCIAGVTVP | 1891 | P58107 | |
| VPGYCQPITTVTASA | 1361 | Q13635 | |
| PGGSTAYVVCGVISF | 181 | A6NL88 | |
| GPVTCLTASPNGLYV | 81 | Q9BV38 | |
| VIDPVTGKPCAGTTY | 91 | Q9Y2R5 | |
| LYPSEAGCPVGQTRT | 3621 | Q9P2P6 | |
| ACGTPGYVAPEVLAQ | 181 | Q8IU85 | |
| SPSIVRCVPGVGIYF | 91 | Q96DW6 | |
| TAISPYLSGVGLGCV | 91 | Q96N87 | |
| GVTCTVPIFEGYSLP | 161 | Q8TDG2 | |
| PESPIGGTITYKCVG | 696 | Q8IZF2 | |
| DTSLYPPGIACVGIF | 41 | H7C241 | |
| PTTVFTPLEYGACGL | 521 | Q16881 | |
| LAVPGVYFTCPLTGA | 116 | Q9BZV1 | |
| TCTIGYVTPDIFIAP | 316 | P60508 | |
| YVGPDSQPLRICTGT | 451 | A6NK02 | |
| SVVTCPQQPSLGGVY | 381 | Q6XQN6 | |
| CLGGTSVGYAIVIPT | 406 | Q9H0V1 | |
| SVGYAIVIPTNFCSP | 411 | Q9H0V1 | |
| AGPPGVVACTEGTTY | 701 | Q9HC78 | |
| PTTVFTPLEYGCVGL | 396 | Q9NNW7 | |
| LPPYSGTVLCGTQAV | 31 | Q14694 | |
| QACVGTTYHPVLPSV | 516 | Q64LD2 | |
| SVPLYPCGVSSSGAE | 361 | Q9BZR9 |